| Patent application number | Description | Published |
|---|
| 20090156934 | Ultrasound Imaging System Including A Graphic Processing Unit - The present invention relates to an ultrasound imaging system. The ultrasound imaging system includes an ultrasound diagnostic unit and an image processing unit. The ultrasound diagnostic unit transmits ultrasound signals to a target object and forms receive data based on ultrasound echo signals reflected from the target object. The image processing unit forms an ultrasound image based on the receive data. The image processing unit includes a graphic processing unit configured to perform at least one of functions including processing the receive data to form image data, performing scan conversion upon the image data to form scan-converted data suitable for display, and rendering and filtering the scan-converted data to form pixel data. | 06-18-2009 |
| 20090171214 | ULTRASOUND SYSTEM AND METHOD OF FORMING ULTRASOUND IMAGE SIGNALS WITH MULTIPROCESSING - The present invention relates to an ultrasound system. The ultrasound system comprises: a probe for transmitting an ultrasound beam along a plurality of scan lines in a target object and output receive signals based on ultrasound echoes reflected from the target object; a beam forming unit for applying delays to the receive signals and sum the delayed receive signals to thereby form scan line signals corresponding to the respective scan lines; a multiprocessing unit including a plurality of processors, each being configured to individually process a part of the scan line signals to output sub-image signals, the multiprocessing unit being configured to synthesize the sub-image signals to output ultrasound image signals corresponding to one image frame; and an image processing unit for performing an image processing upon the ultrasound image signals for display. | 07-02-2009 |
| 20090247874 | USER INTERFACE IN AN ULTRASOUND SYSTEM - Embodiments of a user interface in an ultrasound system are disclosed. In one embodiment, the ultrasound system comprises a display unit for prompting a user to touch a desired one of hierarchically arranged soft buttons for triggering an execution of the function of the ultrasound system associated with the touched button. The display unit includes a display having a display with touch panel mounted. The display unit is configured to display a touch screen menu together with the ultrasound image on the display. | 10-01-2009 |
| 20110191724 | DEVICE FOR ITEM CONTROL, SYSTEM FOR ITEM CONTROL, AND METHOD - A first device classifies and displays an item, identifies a suitable class matched to approach information of a second device out of the entire area of the classified item as the second device approaches the first device, and provides the second device with the identified class or executes a service linked to the class. The second device approaches a portion where a desired class is displayed by the first device, receives the class from the first device, and provides a linked service using the same. | 08-04-2011 |
| 20120100169 | Vaccine for Cervical Cancer - The present invention relates to a pharmaceutical vaccine composition for a human cervical cancer, comprising: (a) (i) a L1 virus-like particle (VLP) of human papillomavirus (HPV) type 16, a L1 VLP of HPV type 18, or a combination thereof; and (ii) a deacylated non-toxic lipooligosaccharide (LOS); and (b) a pharmaceutically acceptable carrier; and a method for preparing a human papillomavirus (HPV) L1 virus-like particle (VLP). The pharmaceutical vaccine composition of the present invention is in both Th1-type immune response (cellular immunity) and Th2-type immune response (humoral immunity) against HPV more excellent than Cervrix™ and Gardasil™, exhibiting a superior efficacy as a vaccine for a human cervical cancer. | 04-26-2012 |
| Patent application number | Description | Published |
|---|
| 20100197673 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS - The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient. | 08-05-2010 |
| 20100210647 | INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS - The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient. | 08-19-2010 |
| 20100267708 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT - The present invention relates to new compounds of formula (1) exhibiting excellent activity for glucokinase, and pharmaceutical compositions comprising the same as an active ingredient. | 10-21-2010 |
| 20100291533 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT - The present invention relates to a composition for preserving cells, tissues and organs, comprising as an active ingredient indole and indazole compounds of formula (1), or a pharmaceutically acceptable salt or isomer thereof, which are effective for preventing injury of organs, isolated cell systems or tissues caused by cold storage, transplant operation or post-transplantation reperfusion; a preservation method; and a preparation method of the composition. | 11-18-2010 |
| 20120088760 | GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT - Disclosed are new compounds of formula (1) exhibiting excellent activity for glucokinase, pharmaceutical compositions having the same as an active ingredient, and a method of using the same as an active ingredient for lowering blood glucose level: | 04-12-2012 |
